KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Edwards Lifesciences (EW) Income towards Parent Company (2016 - 2025)

Historic Income towards Parent Company for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to -$2.0 million.

  • Edwards Lifesciences' Income towards Parent Company fell 10007.39% to -$2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.7 million, marking a year-over-year decrease of 9907.25%. This contributed to the annual value of $2.8 billion for FY2024, which is 144609.81% up from last year.
  • Edwards Lifesciences' Income towards Parent Company amounted to -$2.0 million in Q3 2025, which was down 10007.39% from -$4.4 million recorded in Q2 2025.
  • Edwards Lifesciences' 5-year Income towards Parent Company high stood at $2.7 billion for Q3 2024, and its period low was -$7.2 million during Q1 2025.
  • Moreover, its 5-year median value for Income towards Parent Company was $54.1 million (2023), whereas its average is $303.5 million.
  • Its Income towards Parent Company has fluctuated over the past 5 years, first surged by 544774.59% in 2024, then plummeted by 54000.0% in 2025.
  • Over the past 5 years, Edwards Lifesciences' Income towards Parent Company (Quarter) stood at $335.3 million in 2021, then plummeted by 40.2% to $200.5 million in 2022, then tumbled by 81.75% to $36.6 million in 2023, then rose by 7.38% to $39.3 million in 2024, then plummeted by 105.09% to -$2.0 million in 2025.
  • Its last three reported values are -$2.0 million in Q3 2025, -$4.4 million for Q2 2025, and -$7.2 million during Q1 2025.